Law News

Thursday, February 9, 2012

Blog: Cost of patent reexamination may skyrocket
Thomas McNulty of Lando & Anastasi LLP: On Jan. 25, 2012, the U.S. Patent and Trademark Office published a Notice of Proposed Rulemaking, which included a proposal to substantially increase the fees for requesting "ex parte reexamination." This fee increase will certainly affect the number of such requests filed, likely at the expense of innovation.

Monday, February 6, 2012

Chinese court dismisses one of AMSC vs. Sinovel cases
Devens-based AMSC will see one its cases against former partner Sinovel Wind Group Co. Ltd. decided in arbitration, as a Chinese court has thrown out its civil complaint.

Friday, February 3, 2012

Fraud charges dropped on Stryker ex-president Philip
The federal government has dropped fraud charges against former Stryker Biotech president Mark Philip. Philip received indictments in 2009 and 2011, alleging he was involved in marketing an unapproved mixture of products for strengthening human bone growth.

Friday, January 27, 2012

Judge grants stay of preliminary injunction in Momenta Pharma case
Momenta Pharmaceuticals Inc. was dealt a blow Thursday when the U.S. Court of Appeals for the Federal Circuit granted a motion for a stay of the preliminary injunction, pending appeal, from Amphastar Pharmaceuticals Inc., Watson Pharmaceuticals Inc. and International Medical Systems Ltd.

Monday, January 23, 2012

Boston Scientific cleared of 2008 J&J patent suit
Boston Scientific Corp. has won a patent infringement lawsuit that Johnson & Johnson Co. brought against the Natick medical device company in 2008.

Wednesday, January 18, 2012

Tim Berners-Lee fights subpoena from Barnes & Noble
The Father of the Internet, Sir Timothy Berners-Lee, is fighting to stay out of a legal case between Barnes & Noble Inc. and Alcatel Lucent USA Inc. over technology related to the Nook e-book reader.

Thursday, January 12, 2012

Report: Stryker Biotech charged with misbranding
Stryker Biotech and three former sales managers were accused by a prosecutor of putting patients at risk by marketing an unapproved mixture of products to strengthen the growth of human bone, according to a published report.

Thursday, January 5, 2012

Synergy lawsuit against Ironwood dropped
The lawsuit seeking $500 million in damages that Synergy Pharmaceuticals Inc. filed against Cambridge biotech Ironwood Pharmaceuticals Inc. and its chief scientific officer has been withdrawn, according to a U.S. Securities and Exchange Commission Form 8-K filing by Ironwood.

Wednesday, December 14, 2011

SRU Biosystems resolves Resonant patent suit
SRU Biosystems Inc. of Woburn has settled a patent infringement lawsuit originally filed in August with Resonant Biotechnologies LLC of California.

Tuesday, December 13, 2011

Ironwood, chief scientific officer slapped with a $500M lawsuit
Ironwood Pharmaceuticals Inc., a Cambridge biotech company focused on irritable bowel syndrome, has been hit with a lawsuit seeking $500 million in damages by Synergy Pharmaceuticals Inc., a New York developer of drugs for gastrointestinal disorders and diseases.

Tuesday, November 1, 2011

A123 settles patent dispute
Battery maker A123 Systems Inc. of Waltham, Hydro-Quebec and the University of Texas System have settled a series of lawsuits relating to lithium metal phosphate technologies, according to A123.

Friday, October 28, 2011

Appeals court rejects Cape Wind approval
A federal appeals court today overturned the Federal Aviation Administration‘s approval of the Cape Wind project, ordering the agency to reconsider whether 130 440-foot-tall turbines in Nantucket Sound would put air travelers in jeopardy.

Monday, October 24, 2011

Blog: Moneyball, Theo Epstein, and how to protect your trade secrets
Sherin and Lodgen LLP partner Debra Squires-Lee: If former Red Sox GM Theo Epstein was privy to any proprietary, secret, statistical method for analyzing baseball talent, that method may well be a Red Sox trade secret under Massachusetts law. Can Epstein now put it to use to benefit the Cubs?

Wednesday, October 5, 2011

GT Advanced Technologies suits wind down
A pair of class-action stockholder suits against solar manufacturing equipment maker GT Advanced Technologies are drawing to a close with a federal judge delivering final approval of a settlement that will pay major stockholders and their attorneys $10.5 million.

Monday, September 26, 2011

Former AMSC worker pleads guilty in espionage case
Dejan Karabasevic, the engineer and former American Superconductor Corp. employee at the center of AMSC's claims of corporate espionage by Sinovel Wind Group Co. Ltd. has pleaded guilty on charges of passing AMSC secrets to the Chinese company.

Friday, September 16, 2011

Palomar settles patent suit with Syneron, Candela
Palomar Medical Technologies Inc., a laser cosmetic treatment maker in Burlington, has settled a patent infringement dispute with Israeli aesthetic device maker Syneron Medical Ltd., with Palomar collecting $31 million from the settlement.
Haemonetics handed a loss in pair of patent suits
Blood management company Haemonetics Corp. has lost a pair of lawsuits it had brought against Illinois firm Fenwal Inc. over red blood cell separation technology.
FotoMedia sues Facebook, MySpace over photo sharing patents
FotoMedia Technologies LLC, a Portsmouth, N.H., patent holding company focused on photo sharing technologies, has filed patent infringement suits against Facebook and MySpace, among others, according to a release.

Thursday, September 15, 2011

EMC reported to gain rival support in patent troll lawsuit
EMC Corp.'s appeal of a lawsuit filed by a "patent troll" has reportedly prompted support from the Hopkinton data storage giant's rivals Hewlett-Packard Co. and Cisco Systems Inc., the Wall Street Journal has indicated.
Corporate spying case leads AMSC to file charges against Sinovel
American Superconductor Corp. is filing both criminal charges and civil complaints against its one-time largest customer, China’s Sinovel Wind Group Co. Ltd. over alleged theft of AMSC’s intellectual property about its wind turbines, stemming from a corporate espionage case.